Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis

Xuemei Li; Weidong Zhao; Hong Han; Zhi Yang; Fengqing Bi; Yingchun He

doi:10.15537/smj.2024.45.7.20240310

References

1.↵
1. Esmael A,
2. Abebe T,
3. Mihret A,
4. Mussa D,
5. Neway S,
6. Ernst J, et al.
Mycobacterium tuberculosis antigen-specific T-cell responses in smear-negative pulmonary tuberculosis patients. Clin Exp Immunol 2022; 209: 99-108.
OpenUrl
2.↵
1. Asadi L,
2. Croxen M,
3. Heffernan C,
4. Dhillon M,
5. Paulsen C,
6. Egedahl ML, et al.
How much do smear-negative patients really contribute to tuberculosis transmissions? Re-examining an old question with new tools. EClinicalMedicine 2022; 43: 101250.
OpenUrl
3.↵
1. Wu Z,
2. Shi J,
3. Zhou Y,
4. Pan N,
5. Qiu C,
6. Wu L, et al.
The diagnostic value of the thermostatic amplification of ribonucleic acid in bronchoalveolar lavage fluid in smear-negative pulmonary tuberculosis. Front Public Health 2022; 10: 830477.
OpenUrl
4.↵
1. Zhao Z,
2. Wu T,
3. Wang M,
4. Chen X,
5. Liu T,
6. Si Y, et al.
A new droplet digital PCR assay: improving detection of paucibacillary smear-negative pulmonary tuberculosis. Int J Infect Dis 2022; 122: 820-828.
OpenUrl
5.↵
1. Chin KL,
2. Anibarro L,
3. Sarmiento ME,
4. Acosta A
. Challenges and the way forward in diagnosis and treatment of tuberculosis infection. Trop Med Infect Dis 2023; 8: 89.
OpenUrl
6.↵
1. Nziza N,
2. Cizmeci D,
3. Davies L,
4. Irvine EB,
5. Jung W,
6. Fenderson BA, et al.
Defining discriminatory antibody fingerprints in active and latent tuberculosis. Front Immunol 2022; 13: 856906.
OpenUrl
7.↵
1. Zhu F,
2. Ou Q,
3. Zheng J,
4. Zhou M,
5. Chen H,
6. Jiang X
. Role of bronchoalveolar lavage fluid and serum interleukin-27 in the diagnosis of smear-negative pulmonary tuberculosis. Medicine (Baltimore) 2021; 100: e25821.
OpenUrl
8.↵
1. Xu F,
2. Zhang H,
3. Si X,
4. Chen J,
5. Chen Y,
6. Cui X, et al.
Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis. BMC Immunol 2021; 22: 41.
OpenUrl
9.↵
1. Esmael A,
2. Mihret A,
3. Abebe T,
4. Mussa D,
5. Neway S,
6. Ernst J, et al.
Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients. PLoS One 2022; 17: e0271234.
OpenUrl
10.↵
1. Camprubi D,
2. Gomila A,
3. Grijota-Camino MD,
4. Soldevila L,
5. Luque MJ,
6. Alcaide F, et al.
Infectiousness of patients with smear-negative pulmonary tuberculosis, assessed by real-time polymerase chain reaction, Xpert®MTB/RIF. J Infect 2020; 80: 298-300.
OpenUrl
11.↵
1. Khadka P,
2. Thapaliya J,
3. Basnet RB,
4. Ghimire GR,
5. Amatya J,
6. Rijal BP
. Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal. BMC Infect Dis 2019; 19:1090.
OpenUrl
12.↵
1. Luo L,
2. Zhu L,
3. Yue J,
4. Liu J,
5. Liu G,
6. Zhang X, et al.
Antigens Rv0310c and Rv1255c are promising novel biomarkers for the diagnosis of Mycobacterium tuberculosis infection. Emerg Microbes Infect 2017; 6: e64.
OpenUrl
13.↵
1. Ju Y,
2. Jin C,
3. Chen S,
4. Wang J,
5. Li C,
6. Wang X, et al.
Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism. Front Cell Infect Microbiol 2023; 13: 1240516.
OpenUrl
14.↵
1. Hu X,
2. Wang J,
3. Ju Y,
4. Zhang X,
5. Qimanguli W,
6. Li C, et al.
Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis. BMC Infect Dis 2022; 22: 707.
OpenUrl
15.↵
1. Petnak T,
2. Eksombatchai D,
3. Chesdachai S,
4. Lertjitbanjong P,
5. Taweesedt P,
6. Pornchai A, et al.
Diagnostic accuracy of interferon-gamma release assays for diagnosis of smear-negative pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med 2022; 22:219.
OpenUrl
16.↵
1. Zhou G,
2. Luo Q,
3. Luo S,
4. Chen H,
5. Cai S,
6. Guo X, et al.
Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis. Front Immunol 2023; 14: 1170579.
OpenUrl
17.↵
1. Sudbury EL,
2. Clifford V,
3. Messina NL,
4. Song R,
5. Curtis N
. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review. J Infect 2020; 81: 873-881.
OpenUrl
18.↵
1. Ravesloot-Chavez MM,
2. Van Dis E,
3. Stanley SA
. The Innate Immune Response to Mycobacterium tuberculosis Infection. Annu Rev Immunol 2021; 39: 611-637.
OpenUrl CrossRef
19.↵
1. Poladian N,
2. Orujyan D,
3. Narinyan W,
4. Oganyan AK,
5. Navasardyan I,
6. Velpuri P, et al.
Role of NF-kappaB during Mycobacterium tuberculosis Infection. Int J Mol Sci 2023; 24: 1772.
OpenUrl
20.↵
1. Liu QX,
2. Tang DY,
3. Xiang X,
4. He JQ
. Associations between nutritional and immune status and clinicopathologic factors in patients with tuberculosis: A comprehensive analysis. Front Cell Infect Microbiol 2022; 12: 1013751.
OpenUrl
21.↵
1. Shey MS,
2. Balfour A,
3. Masina N,
4. Bekiswa A,
5. Schutz C,
6. Goliath R, et al.
Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with Mycobacterium tuberculosis. Front Immunol 2023; 14: 1176615.
OpenUrl
22.↵
1. Krutikov M,
2. Faust L,
3. Nikolayevskyy V,
4. Hamada Y,
5. Gupta RK,
6. Cirillo D, et al.
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-gamma release assays: a systematic review and meta-analysis. Lancet Infect Dis 2022; 22: 250-264.
OpenUrl
23.↵
1. Ortiz-Brizuela E,
2. Apriani L,
3. Mukherjee T,
4. Lachapelle-Chisholm S,
5. Miedy M,
6. Lan Z, et al.
Assessing the diagnostic performance of new commercial interferon-gamma release assays for mycobacterium tuberculosis infection: A systematic review and meta-analysis. Clin Infect Dis 2023; 76: 1989-1999.
OpenUrl
24.↵
1. Zhang SX,
2. Lu ZH,
3. Wang MT,
4. Shen YP,
5. Duan L,
6. Guan SY, et al.
Assessing the association between the circulating levels of inflammatory cytokines and the risk of tuberculosis: A bidirectional two-sample mendelian randomization study. Infect Genet Evol 2023; 116: 105524.
OpenUrl
25.↵
1. Vivekanandan MM,
2. Adankwah E,
3. Aniagyei W,
4. Acheampong I,
5. Yeboah A,
6. Arthur JF, et al.
Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients. Infection 2023; 51: 169-179.
OpenUrl
26.↵
1. Thirunavukkarasu S,
2. Ahmed M,
3. Rosa BA,
4. Boothby M,
5. Cho SH,
6. Rangel-Moreno J, et al.
Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production. J Clin Invest 2023; 133:e158630.
OpenUrl
27.↵
1. Taneja V,
2. Kalra P,
3. Goel M,
4. Khilnani GC,
5. Saini V,
6. Prasad G, et al.
Impact and prognosis of the expression of IFN-alpha among tuberculosis patients. PLoS One 2020; 15: e0235488.
OpenUrl
28.
1. Mundra A,
2. Yegiazaryan A,
3. Karsian H,
4. Alsaigh D,
5. Bonavida V,
6. Frame M, et al.
Pathogenicity of type I interferons in Mycobacterium tuberculosis. Int J Mol Sci 2023; 24: 3919.
OpenUrl
29.↵
1. Liu X,
2. Li F,
3. Niu H,
4. Ma L,
5. Chen J,
6. Zhang Y, et al.
IL-2 Restores T-Cell Dysfunction induced by persistent Mycobacterium tuberculosis Antigen stimulation. Front Immunol 2019; 10: 2350.
OpenUrl PubMed
30.↵
1. Wong EA,
2. Evans S,
3. Kraus CR,
4. Engelman KD,
5. Maiello P,
6. Flores WJ, et al.
IL-10 impairs local immune response in lung granulomas and lymph nodes during early Mycobacterium tuberculosis infection. J Immunol 2020; 204: 644-659.
OpenUrl Abstract/FREE Full Text
31.↵
1. Flores-Gonzalez J,
2. Urban-Solano A,
3. Ramon-Luing LA,
4. Cancino-Diaz JC,
5. Contreras-Rodriguez A,
6. Curiel-Quesada E, et al.
Active tuberculosis patients have high systemic IgG levels and B-cell fingerprinting, characterized by a reduced capacity to produce IFN-γ or IL-10 as a response to M.tb antigens. Front Immunol 2023; 14: 1263458.
OpenUrl
32.↵
1. Okeke CO,
2. Amilo GI,
3. Manafa PO,
4. Ibeh NC
. Inflammation-mediated changes in haemostatic variables of pulmonary tuberculosis patients during treatment. Tuberculosis (Edinb) 2023; 138: 102285.
OpenUrl
33.↵
1. La Manna MP,
2. Orlando V,
3. Paraboschi EM,
4. Tamburini B,
5. Di Carlo P,
6. Cascio A, et al.
Mycobacterium tuberculosis drives expansion of low-density neutrophils equipped with regulatory activities. Front Immunol 2019; 10:2761.
OpenUrl
34.↵
1. Suzukawa M,
2. Takeda K,
3. Akashi S,
4. Asari I,
5. Kawashima M,
6. Ohshima N, et al.
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis. J Infect 2020; 80: 547-553.
OpenUrl

In this issue

Download PDF

Email Article

Citation Tools

Bookmark this article

Cited By...

No citing articles found.

Google Scholar

More in this TOC Section

Show more Original Article

Keywords

[1] 1.↵
Esmael A,
Abebe T,
Mihret A,
Mussa D,
Neway S,
Ernst J, et al.
Mycobacterium tuberculosis antigen-specific T-cell responses in smear-negative pulmonary tuberculosis patients. Clin Exp Immunol 2022; 209: 99-108.
OpenUrl

[2] Esmael A,

[3] Abebe T,

[4] Mihret A,

[5] Mussa D,

[6] Neway S,

[7] Ernst J, et al.

[8] 2.↵
Asadi L,
Croxen M,
Heffernan C,
Dhillon M,
Paulsen C,
Egedahl ML, et al.
How much do smear-negative patients really contribute to tuberculosis transmissions? Re-examining an old question with new tools. EClinicalMedicine 2022; 43: 101250.
OpenUrl

[9] Asadi L,

[10] Croxen M,

[11] Heffernan C,

[12] Dhillon M,

[13] Paulsen C,

[14] Egedahl ML, et al.

[15] 3.↵
Wu Z,
Shi J,
Zhou Y,
Pan N,
Qiu C,
Wu L, et al.
The diagnostic value of the thermostatic amplification of ribonucleic acid in bronchoalveolar lavage fluid in smear-negative pulmonary tuberculosis. Front Public Health 2022; 10: 830477.
OpenUrl

[16] Wu Z,

[17] Shi J,

[18] Zhou Y,

[19] Pan N,

[20] Qiu C,

[21] Wu L, et al.

[22] 4.↵
Zhao Z,
Wu T,
Wang M,
Chen X,
Liu T,
Si Y, et al.
A new droplet digital PCR assay: improving detection of paucibacillary smear-negative pulmonary tuberculosis. Int J Infect Dis 2022; 122: 820-828.
OpenUrl

[23] Zhao Z,

[24] Wu T,

[25] Wang M,

[26] Chen X,

[27] Liu T,

[28] Si Y, et al.

[29] 5.↵
Chin KL,
Anibarro L,
Sarmiento ME,
Acosta A
. Challenges and the way forward in diagnosis and treatment of tuberculosis infection. Trop Med Infect Dis 2023; 8: 89.
OpenUrl

[30] Chin KL,

[31] Anibarro L,

[32] Sarmiento ME,

[33] Acosta A

[34] 6.↵
Nziza N,
Cizmeci D,
Davies L,
Irvine EB,
Jung W,
Fenderson BA, et al.
Defining discriminatory antibody fingerprints in active and latent tuberculosis. Front Immunol 2022; 13: 856906.
OpenUrl

[35] Nziza N,

[36] Cizmeci D,

[37] Davies L,

[38] Irvine EB,

[39] Jung W,

[40] Fenderson BA, et al.

[41] 7.↵
Zhu F,
Ou Q,
Zheng J,
Zhou M,
Chen H,
Jiang X
. Role of bronchoalveolar lavage fluid and serum interleukin-27 in the diagnosis of smear-negative pulmonary tuberculosis. Medicine (Baltimore) 2021; 100: e25821.
OpenUrl

[42] Zhu F,

[43] Ou Q,

[44] Zheng J,

[45] Zhou M,

[46] Chen H,

[47] Jiang X

[48] 8.↵
Xu F,
Zhang H,
Si X,
Chen J,
Chen Y,
Cui X, et al.
Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis. BMC Immunol 2021; 22: 41.
OpenUrl

[49] Xu F,

[50] Zhang H,

[51] Si X,

[52] Chen J,

[53] Chen Y,

[54] Cui X, et al.

[55] 9.↵
Esmael A,
Mihret A,
Abebe T,
Mussa D,
Neway S,
Ernst J, et al.
Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients. PLoS One 2022; 17: e0271234.
OpenUrl

[56] Esmael A,

[57] Mihret A,

[58] Abebe T,

[59] Mussa D,

[60] Neway S,

[61] Ernst J, et al.

[62] 10.↵
Camprubi D,
Gomila A,
Grijota-Camino MD,
Soldevila L,
Luque MJ,
Alcaide F, et al.
Infectiousness of patients with smear-negative pulmonary tuberculosis, assessed by real-time polymerase chain reaction, Xpert®MTB/RIF. J Infect 2020; 80: 298-300.
OpenUrl

[63] Camprubi D,

[64] Gomila A,

[65] Grijota-Camino MD,

[66] Soldevila L,

[67] Luque MJ,

[68] Alcaide F, et al.

[69] 11.↵
Khadka P,
Thapaliya J,
Basnet RB,
Ghimire GR,
Amatya J,
Rijal BP
. Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal. BMC Infect Dis 2019; 19:1090.
OpenUrl

[70] Khadka P,

[71] Thapaliya J,

[72] Basnet RB,

[73] Ghimire GR,

[74] Amatya J,

[75] Rijal BP

[76] 12.↵
Luo L,
Zhu L,
Yue J,
Liu J,
Liu G,
Zhang X, et al.
Antigens Rv0310c and Rv1255c are promising novel biomarkers for the diagnosis of Mycobacterium tuberculosis infection. Emerg Microbes Infect 2017; 6: e64.
OpenUrl

[77] Luo L,

[78] Zhu L,

[79] Yue J,

[80] Liu J,

[81] Liu G,

[82] Zhang X, et al.

[83] 13.↵
Ju Y,
Jin C,
Chen S,
Wang J,
Li C,
Wang X, et al.
Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism. Front Cell Infect Microbiol 2023; 13: 1240516.
OpenUrl

[84] Ju Y,

[85] Jin C,

[86] Chen S,

[87] Wang J,

[88] Li C,

[89] Wang X, et al.

[90] 14.↵
Hu X,
Wang J,
Ju Y,
Zhang X,
Qimanguli W,
Li C, et al.
Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis. BMC Infect Dis 2022; 22: 707.
OpenUrl

[91] Hu X,

[92] Wang J,

[93] Ju Y,

[94] Zhang X,

[95] Qimanguli W,

[96] Li C, et al.

[97] 15.↵
Petnak T,
Eksombatchai D,
Chesdachai S,
Lertjitbanjong P,
Taweesedt P,
Pornchai A, et al.
Diagnostic accuracy of interferon-gamma release assays for diagnosis of smear-negative pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med 2022; 22:219.
OpenUrl

[98] Petnak T,

[99] Eksombatchai D,

[100] Chesdachai S,

[101] Lertjitbanjong P,

[102] Taweesedt P,

[103] Pornchai A, et al.

[104] 16.↵
Zhou G,
Luo Q,
Luo S,
Chen H,
Cai S,
Guo X, et al.
Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis. Front Immunol 2023; 14: 1170579.
OpenUrl

[105] Zhou G,

[106] Luo Q,

[107] Luo S,

[108] Chen H,

[109] Cai S,

[110] Guo X, et al.

[111] 17.↵
Sudbury EL,
Clifford V,
Messina NL,
Song R,
Curtis N
. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review. J Infect 2020; 81: 873-881.
OpenUrl

[112] Sudbury EL,

[113] Clifford V,

[114] Messina NL,

[115] Song R,

[116] Curtis N

[117] 18.↵
Ravesloot-Chavez MM,
Van Dis E,
Stanley SA
. The Innate Immune Response to Mycobacterium tuberculosis Infection. Annu Rev Immunol 2021; 39: 611-637.
OpenUrl CrossRef

[118] Ravesloot-Chavez MM,

[119] Van Dis E,

[120] Stanley SA

[121] 19.↵
Poladian N,
Orujyan D,
Narinyan W,
Oganyan AK,
Navasardyan I,
Velpuri P, et al.
Role of NF-kappaB during Mycobacterium tuberculosis Infection. Int J Mol Sci 2023; 24: 1772.
OpenUrl

[122] Poladian N,

[123] Orujyan D,

[124] Narinyan W,

[125] Oganyan AK,

[126] Navasardyan I,

[127] Velpuri P, et al.

[128] 20.↵
Liu QX,
Tang DY,
Xiang X,
He JQ
. Associations between nutritional and immune status and clinicopathologic factors in patients with tuberculosis: A comprehensive analysis. Front Cell Infect Microbiol 2022; 12: 1013751.
OpenUrl

[129] Liu QX,

[130] Tang DY,

[131] Xiang X,

[132] He JQ

[133] 21.↵
Shey MS,
Balfour A,
Masina N,
Bekiswa A,
Schutz C,
Goliath R, et al.
Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with Mycobacterium tuberculosis. Front Immunol 2023; 14: 1176615.
OpenUrl

[134] Shey MS,

[135] Balfour A,

[136] Masina N,

[137] Bekiswa A,

[138] Schutz C,

[139] Goliath R, et al.

[140] 22.↵
Krutikov M,
Faust L,
Nikolayevskyy V,
Hamada Y,
Gupta RK,
Cirillo D, et al.
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-gamma release assays: a systematic review and meta-analysis. Lancet Infect Dis 2022; 22: 250-264.
OpenUrl

[141] Krutikov M,

[142] Faust L,

[143] Nikolayevskyy V,

[144] Hamada Y,

[145] Gupta RK,

[146] Cirillo D, et al.

[147] 23.↵
Ortiz-Brizuela E,
Apriani L,
Mukherjee T,
Lachapelle-Chisholm S,
Miedy M,
Lan Z, et al.
Assessing the diagnostic performance of new commercial interferon-gamma release assays for mycobacterium tuberculosis infection: A systematic review and meta-analysis. Clin Infect Dis 2023; 76: 1989-1999.
OpenUrl

[148] Ortiz-Brizuela E,

[149] Apriani L,

[150] Mukherjee T,

[151] Lachapelle-Chisholm S,

[152] Miedy M,

[153] Lan Z, et al.

[154] 24.↵
Zhang SX,
Lu ZH,
Wang MT,
Shen YP,
Duan L,
Guan SY, et al.
Assessing the association between the circulating levels of inflammatory cytokines and the risk of tuberculosis: A bidirectional two-sample mendelian randomization study. Infect Genet Evol 2023; 116: 105524.
OpenUrl

[155] Zhang SX,

[156] Lu ZH,

[157] Wang MT,

[158] Shen YP,

[159] Duan L,

[160] Guan SY, et al.

[161] 25.↵
Vivekanandan MM,
Adankwah E,
Aniagyei W,
Acheampong I,
Yeboah A,
Arthur JF, et al.
Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients. Infection 2023; 51: 169-179.
OpenUrl

[162] Vivekanandan MM,

[163] Adankwah E,

[164] Aniagyei W,

[165] Acheampong I,

[166] Yeboah A,

[167] Arthur JF, et al.

[168] 26.↵
Thirunavukkarasu S,
Ahmed M,
Rosa BA,
Boothby M,
Cho SH,
Rangel-Moreno J, et al.
Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production. J Clin Invest 2023; 133:e158630.
OpenUrl

[169] Thirunavukkarasu S,

[170] Ahmed M,

[171] Rosa BA,

[172] Boothby M,

[173] Cho SH,

[174] Rangel-Moreno J, et al.

[175] 27.↵
Taneja V,
Kalra P,
Goel M,
Khilnani GC,
Saini V,
Prasad G, et al.
Impact and prognosis of the expression of IFN-alpha among tuberculosis patients. PLoS One 2020; 15: e0235488.
OpenUrl

[176] Taneja V,

[177] Kalra P,

[178] Goel M,

[179] Khilnani GC,

[180] Saini V,

[181] Prasad G, et al.

[182] 28.
Mundra A,
Yegiazaryan A,
Karsian H,
Alsaigh D,
Bonavida V,
Frame M, et al.
Pathogenicity of type I interferons in Mycobacterium tuberculosis. Int J Mol Sci 2023; 24: 3919.
OpenUrl

[183] Mundra A,

[184] Yegiazaryan A,

[185] Karsian H,

[186] Alsaigh D,

[187] Bonavida V,

[188] Frame M, et al.

[189] 29.↵
Liu X,
Li F,
Niu H,
Ma L,
Chen J,
Zhang Y, et al.
IL-2 Restores T-Cell Dysfunction induced by persistent Mycobacterium tuberculosis Antigen stimulation. Front Immunol 2019; 10: 2350.
OpenUrl PubMed

[190] Liu X,

[191] Li F,

[192] Niu H,

[193] Ma L,

[194] Chen J,

[195] Zhang Y, et al.

[196] 30.↵
Wong EA,
Evans S,
Kraus CR,
Engelman KD,
Maiello P,
Flores WJ, et al.
IL-10 impairs local immune response in lung granulomas and lymph nodes during early Mycobacterium tuberculosis infection. J Immunol 2020; 204: 644-659.
OpenUrl Abstract/FREE Full Text

[197] Wong EA,

[198] Evans S,

[199] Kraus CR,

[200] Engelman KD,

[201] Maiello P,

[202] Flores WJ, et al.

[203] 31.↵
Flores-Gonzalez J,
Urban-Solano A,
Ramon-Luing LA,
Cancino-Diaz JC,
Contreras-Rodriguez A,
Curiel-Quesada E, et al.
Active tuberculosis patients have high systemic IgG levels and B-cell fingerprinting, characterized by a reduced capacity to produce IFN-γ or IL-10 as a response to M.tb antigens. Front Immunol 2023; 14: 1263458.
OpenUrl

[204] Flores-Gonzalez J,

[205] Urban-Solano A,

[206] Ramon-Luing LA,

[207] Cancino-Diaz JC,

[208] Contreras-Rodriguez A,

[209] Curiel-Quesada E, et al.

[210] 32.↵
Okeke CO,
Amilo GI,
Manafa PO,
Ibeh NC
. Inflammation-mediated changes in haemostatic variables of pulmonary tuberculosis patients during treatment. Tuberculosis (Edinb) 2023; 138: 102285.
OpenUrl

[211] Okeke CO,

[212] Amilo GI,

[213] Manafa PO,

[214] Ibeh NC

[215] 33.↵
La Manna MP,
Orlando V,
Paraboschi EM,
Tamburini B,
Di Carlo P,
Cascio A, et al.
Mycobacterium tuberculosis drives expansion of low-density neutrophils equipped with regulatory activities. Front Immunol 2019; 10:2761.
OpenUrl

[216] La Manna MP,

[217] Orlando V,

[218] Paraboschi EM,

[219] Tamburini B,

[220] Di Carlo P,

[221] Cascio A, et al.

[222] 34.↵
Suzukawa M,
Takeda K,
Akashi S,
Asari I,
Kawashima M,
Ohshima N, et al.
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis. J Infect 2020; 80: 547-553.
OpenUrl

[223] Suzukawa M,

[224] Takeda K,

[225] Akashi S,

[226] Asari I,

[227] Kawashima M,

[228] Ohshima N, et al.

Main menu

User menu

Search

Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

CONTENT

JOURNAL

AUTHORS

Main menu

User menu

Search

Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis

References

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

CONTENT

JOURNAL

AUTHORS